Paclitaxel-bromothiophene
Paclitaxel-bromothiophene is a semisynthetic taxane analogue of Paclitaxel (HY-B0015) . Paclitaxel-bromothiophene exhibits potent antiproliferative activity against 4-T1 breast cancer cells, with an IC50 value of 15.18 nM. Paclitaxel-bromothiophene shows high binding affinity to C5aR1 (Kd = 19.4 μM) . Paclitaxel-bromothiophene demonstrates excellent anti-tumor efficacy in 4-T1 breast cancer-bearing mice. Paclitaxel-bromothiophene can be used for the study of breast cancer[1].
Product Specifications
UNSPSC
12352005
Target
Drug Derivative
Related Pathways
Others
Field of Research
Cancer
Smiles
O=C1[C@H](OC(C)=O)C(C2(C)C)=C(C)[C@@H](OC([C@H](O)[C@@H](NC(C3=CC=CC=C3)=O)C4=CC=C(Br)S4)=O)C[C@@]2(O)[C@@H](OC(C5=CC=CC=C5)=O)C6[C@@]1(C)[C@@H](O)C[C@@]7([H])OC[C@]76OC(C)=O
Molecular Formula
C45H48BrNO14S
Molecular Weight
938.83
References & Citations
[1]Fu X, et al. Multicomponent Reaction-Enabled Semisynthesis of Taxanes Yields an Analogue with Reduced Chemotherapy-Induced Neuropathy. JACS Au. 2025 Aug 25;5 (9) :4299-4308.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
